Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 23, 2022
Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophy
Emily Gibbons, Daniel Whittam, Kariem Elhadd, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 23, 2024
The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis
Chiara Rocchi, Mirasol Forcadela, Patricia Kelly, et al.
Practical Neurology
|
December 7, 2018
Intracranial dural arteriovenous fistula mistaken as cervical transverse myelitis
Gowri A Peethambar, Daniel H Whittam, Saif Huda, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 15, 2023
IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation
Michelangelo Cao, Wei-Wei Liu, Susan Maxwell, et al.
The Journal of the Royal College of Physicians of Edinburgh
|
June 13, 2019
Steroid refractory giant cell arteritis with bilateral vertebral artery occlusion and middle cerebellar peduncle infarction
Sarah Healy, Mark Simpson, William J Kitchen, et al.
Multiple Sclerosis and Related Disorders
|
March 13, 2024
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
Moneeb Nasir, Luke Hone, Emma Tallantyre, et al.
Annals of Clinical and Translational Neurology
|
June 17, 2024
Characterizing mortality in patients with AQP4-Ab+ neuromyelitis optica spectrum disorder
Anna Francis, Emily Gibbons, Jeffrey Yu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 17, 2023
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria
Mirasol Forcadela, Chiara Rocchi, Daniel San Martin, et al.
Annals of Clinical and Translational Neurology
|
May 15, 2021
No strong HLA association with MOG antibody disease in the UK population
Melissa Grant-Peters, Giordani Rodrigues Dos Passos, Hing-Yuen Yeung, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 14, 2019
SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
Saif Huda, Michelangelo Cao, Anna De Rosa, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 23, 2022
Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophy
Emily Gibbons, Daniel Whittam, Kariem Elhadd, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 23, 2024
The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis
Chiara Rocchi, Mirasol Forcadela, Patricia Kelly, et al.
Practical Neurology
|
December 7, 2018
Intracranial dural arteriovenous fistula mistaken as cervical transverse myelitis
Gowri A Peethambar, Daniel H Whittam, Saif Huda, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 15, 2023
IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation
Michelangelo Cao, Wei-Wei Liu, Susan Maxwell, et al.
The Journal of the Royal College of Physicians of Edinburgh
|
June 13, 2019
Steroid refractory giant cell arteritis with bilateral vertebral artery occlusion and middle cerebellar peduncle infarction
Sarah Healy, Mark Simpson, William J Kitchen, et al.
Multiple Sclerosis and Related Disorders
|
March 13, 2024
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
Moneeb Nasir, Luke Hone, Emma Tallantyre, et al.
Annals of Clinical and Translational Neurology
|
June 17, 2024
Characterizing mortality in patients with AQP4-Ab+ neuromyelitis optica spectrum disorder
Anna Francis, Emily Gibbons, Jeffrey Yu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 17, 2023
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria
Mirasol Forcadela, Chiara Rocchi, Daniel San Martin, et al.
Annals of Clinical and Translational Neurology
|
May 15, 2021
No strong HLA association with MOG antibody disease in the UK population
Melissa Grant-Peters, Giordani Rodrigues Dos Passos, Hing-Yuen Yeung, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 14, 2019
SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
Saif Huda, Michelangelo Cao, Anna De Rosa, et al.
Page
of 8